What Did Not Change on July 23 No approved indication or dosing label exists The committee did not create an approved indication for ulcerative colitis, tendon injury, ligament injury, muscle recovery, joint pain, gut symptoms, or general wellness
That's an important gap compared to GHK-Cu, which has published human research
[PubMed] [Google Scholar] 118.Zoungas S., McGrath B.P., Branley P., Kerr P.G., Muske C., Wolfe R., Atkins R.C., Nicholls K., Fraenkel M., Hutchison B.G., et al
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Subscribe & Save 10% Off 2026 All Rights Reserved Nxt Level Labz